Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-08-049936
Filing Date
2008-08-26
Accepted
2008-08-26 18:27:30
Documents
1
Period of Report
2008-08-22

Document Format Files

Seq Description Document Type Size
1 v124972_ex.html 3  
1 v124972_ex.xml 3 3683
  Complete submission text file 0001144204-08-049936.txt   5555
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Issuer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVE NEW YORK NY 10022
Business Address C/O PARAMONT CAPITAL INC 787 SEVENTH AVENE 44TH FL NEW YORK NY 10019 2125315965
WEISS MICHAEL S (Reporting) CIK: 0001038977 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51310 | Film No.: 081040259